Carboplatin in Patients With Progressive Gliomas

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of carboplatin in patients with progressive glioma.

Key facts

Study ID

NCT00002749

Run by

Duke University

People needed

25

Starts

1993-02-01

Expected to finish

2000-03-01

Last updated by the study team

2009-10-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Duke Comprehensive Cancer Center — Durham, North Carolina, United States
• Hopital Sainte Justine — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.